Semnur and Denali enter into a letter of intent for proposed business combination
Semnur Prescription drugs, an entirely owned subsidiary of Scilex Holding Firm (NASDAQ:SCLX) and Denali Capital Acquisition (NASDAQ:DECA), a particular goal ...
Tag: Semnur